Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001558370-22-006579
Filing Date
2022-05-02
Accepted
2022-05-02 08:51:59
Documents
16
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A ampe-20211231x10ka.htm   iXBRL 10-K/A 717486
2 EX-31.3 ampe-20211231xex31d3.htm EX-31.3 4739
3 EX-31.4 ampe-20211231xex31d4.htm EX-31.4 4301
4 GRAPHIC ampe-20211231x10ka004.jpg GRAPHIC 3040
  Complete submission text file 0001558370-22-006579.txt   1016582

Data Files

Seq Description Document Type Size
5 EX-101.SCH ampe-20211231.xsd EX-101.SCH 4258
6 EX-101.DEF ampe-20211231_def.xml EX-101.DEF 32793
7 EX-101.LAB ampe-20211231_lab.xml EX-101.LAB 21488
8 EX-101.PRE ampe-20211231_pre.xml EX-101.PRE 17003
10 EXTRACTED XBRL INSTANCE DOCUMENT ampe-20211231x10ka_htm.xml XML 8336
Mailing Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Filer) CIK: 0001411906 (see all company filings)

EIN.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-35182 | Film No.: 22879583
SIC: 2834 Pharmaceutical Preparations